Medsafe

The date for the reclassification of codeine coming into force will not be 31 January 2020, Medsafe group manager Chris James says

The industry body representing medicines manufacturers is concerned a lack of clarity around the upcoming codeine-containing medicines reclassification may result in a situation like the recent dextromethorphan-containing medicines “shambles”

The pharmacy sector has less than three weeks to have a say on the draft Therapeutic Products Bill, which has the potential to change the way pharmacies are licensed and operated

The latest pharmacy audit results show some improvement but Medsafe says it is still observing a lower standard of practice than expected

The Pharmacy Council and Medsafe have signed a memorandum of understanding to make it easier for the organisations to share information and subsequently do a better job as regulators

The makers of Arthrem have appeared in Wellington District Court

Last week’s surprise change to cough medicine classifications will result in more than 200,000 products being recalled and cost manufacturers hundreds of thousands of dollars, a pharmaceutical industry body says.

Supermarkets in Auckland were this morning selling dextromethorphan-containing cough medicines at marked-down prices, five days after a sudden law change making these items pharmacist-only

Some pharmacies unknowingly continued to sell products illegally this week after Medsafe announcements failed to filter through

The maker of herbal supplement Arthrem plans to fight charges laid by the Ministry of Health over reports of liver harm linked to the supplement